Natera executive sells shares for RSU tax withholding

Natera, Inc. president of clinical diagnostics Solomon Moshkevich reported an open-market sale of 1,652 shares of common stock at $202.8398 per share.

Rhea-AI Filing Summary

Natera, Inc. president of clinical diagnostics Solomon Moshkevich reported an open-market sale of 1,652 shares of common stock at $202.8398 per share. According to the footnote, the sale was made to satisfy tax withholding obligations tied to RSU vesting under a written instruction intended to meet Rule 10b5-1(c) conditions. Following the transaction, he directly holds 140,643 shares.

Insider Trade Summary 10b5-1

Net Seller: 1,652 shares

Net Sell 1 txn

Insider Moshkevich Solomon

Role PRESIDENT, CLINICALDIAGNOSTICS

Sold 1,652 shs ($335K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,652	$202.8398	$335K

Holdings After Transaction: Common Stock — 140,643 shares (Direct)

Footnotes (1)

1. F1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on June 10, 2022.

Key Figures

Shares sold: 1,652 shares Sale price: $202.8398 per share Transaction value: $335,000+ +2 more

5 metrics

Shares sold 1,652 shares Open-market sale on 2026-05-26

Sale price $202.8398 per share Natera common stock

Transaction value $335,000+ Approximate gross proceeds from 1,652-share sale

Shares owned after 140,643 shares Direct holdings following transaction

Net share change -1,652 shares Net-sell direction in transaction summary

Key Terms

RSUs, tax withholding, Rule 10b5-1(c), Stock Unit Agreement

4 terms

RSUs financial

"in connection with the vesting of RSUs and made pursuant"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

tax withholding financial

"The sale of shares was effected in order to satisfy tax withholding and remittance obligations"

Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.

Rule 10b5-1(c) regulatory

"intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act"

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

Stock Unit Agreement financial

"contained in the Reporting Person's Stock Unit Agreement granted on June 10, 2022"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Natera (NTRA) executive Solomon Moshkevich report in this Form 4?

Solomon Moshkevich reported selling 1,652 shares of Natera common stock at $202.8398 per share. The filing states the sale was linked to tax withholding for RSU vesting under a written Rule 10b5-1(c) instruction.

How many Natera (NTRA) shares does Solomon Moshkevich hold after the reported sale?

After the sale, Solomon Moshkevich directly holds 140,643 shares of Natera common stock. This position is disclosed in the Form 4 as the total number of shares beneficially owned following the 1,652-share open-market transaction.

What was the purpose of Solomon Moshkevich’s Natera (NTRA) share sale?

The filing states the sale was effected to satisfy tax withholding and remittance obligations related to RSU vesting. It was executed under written instructions in his stock unit agreement intended to meet the affirmative defense conditions of Rule 10b5-1(c).

Was the Natera (NTRA) insider sale under a Rule 10b5-1 trading arrangement?

Yes. The footnote explains the sale was made pursuant to a written instruction in the reporting person’s stock unit agreement. That instruction is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

What type of transaction was reported for Natera (NTRA) in this Form 4?

The Form 4 reports a non-derivative open-market sale of Natera common stock coded “S.” It covers 1,652 shares sold at $202.8398 per share, with the filing describing it as a sale in open market or private transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 09:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moshkevich Solomon

(Last) (First) (Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN TEXAS 78753

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT, CLINICALDIAGNOSTICS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/26/2026		S		1,652(1)	D	$202.8398	140,643	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on June 10, 2022.

	/s/ Tami Chen, Attorney-in-Fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)